The Patent Finder

CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains

Ablynx N.V.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/603,622, filed Feb 27, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,458,235Method for Treating a CX3CR1-ASSOCIATED Disease with CX3CR1-BINDING Polypeptides
In force
 · High confidence
Ablynx N.V.In force
High confidence
US 11,384,151CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In force
High confidence
US 9,783,612CX3CR1-BINDING Polypeptides
In force
 · High confidence
Ablynx N.V.In force
High confidence
US 10,385,134CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In force
High confidence
US 9,035,029CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In force
High confidence
US 12,221,487Nucleic Acids Encoding CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains
In force
 · High confidence
Ablynx N.V.In force
High confidence
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited